Brain Imaging Findings in Multiple System Atrophy vs. Parkinson's Disease
MRI is the optimal imaging modality for differentiating Multiple System Atrophy (MSA) from Parkinson's Disease (PD), with MSA showing characteristic putaminal atrophy, brainstem atrophy, and infratentorial abnormalities that are typically absent or mild in PD. 1, 2
Key MRI Findings
Multiple System Atrophy (MSA)
Putaminal abnormalities:
Infratentorial abnormalities:
Parkinson's Disease (PD)
- Generally normal or near-normal MRI appearance 1
- When abnormalities present, they are typically mild:
MSA Variants Differentiation
MSA-P (parkinsonian variant):
MSA-C (cerebellar variant):
Functional Imaging
- DaT Scan (I-123 ioflupane SPECT/CT):
Diagnostic Algorithm
Initial MRI evaluation:
- Look for putaminal atrophy and hypointensity (moderate-severe suggests MSA)
- Assess brainstem and cerebellar structures (atrophy suggests MSA)
- Calculate putamen/caudate volume ratio (ratio <1.6 suggests MSA) 4
For uncertain cases:
Common Pitfalls
- Relying solely on DaT scan for differentiation (cannot distinguish MSA from PD) 2
- Overlooking mild structural abnormalities in early MSA
- Not considering MSA variants (MSA-P vs MSA-C) which have different imaging emphasis 6
- Failing to use quantitative measures like putamen/caudate volume ratio which can improve diagnostic accuracy 4
The combination of these MRI findings, particularly putaminal atrophy, brainstem atrophy, and cerebellar abnormalities, provides the most reliable imaging-based differentiation between MSA and PD, with approximately 80-90% diagnostic accuracy when using appropriate criteria 3, 4.